Advanced therapeutics, including cell and gene therapies, have the potential to completely revolutionize the state of healthcare, and speed is of the essence. Knowing your CDMO partner has the expertise, capacity, and global supply network is increasingly critical to seamlessly transition from clinic to commercial with confidence. Thermo Fisher Scientific offers the confidence of partnering with an experienced CDMO, combining scale with breadth of services and support network to meet your critical timelines.
Save time and effort with end-to-end solutions to get your therapy to market faster.
With 20+ years of cGMP advanced therapeutics manufacturing experience and 3,500+ scientists and technicians, Thermo Fisher Scientific has the experience and expertise to deliver.
Flexible network of 45 drug substance suites worldwide with more than 650,000 ft2 capacity ensures we can address increasingly complex customer needs.
With integrated clinical and commercial cGMP manufacturing and supply chain solutions across advanced therapy modalities including mRNA and cell and gene therapies, Thermo Fisher Scientific’s broad service offering and extensive network can help you efficiently serve patients worldwide.